An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
NCT00939783
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
649
Enrollment
INDUSTRY
Sponsor class
Stopped
See termination reason in detailed description.
Conditions
Alzheimer's Disease
Interventions
DRUG:
Dimebon
Sponsor
Pfizer
Collaborators
[object Object]